Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Parmer

Showing results (21-30 of 79) with videos related to

Pageof 8
Sort By:
Clinical Pharmacokinetics|May 1, 1991
Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiencyD A Sica, R E Cutler, R J Parmer, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1989
Molecular cloning of chromogranin A from rat pheochromocytoma cellsR J Parmer, A H Koop, M T Handa, et al.
Journal of Clinical Hypertension|December 1, 1987
Serum zinc is unaffected by effective captopril treatment of hypertensionD T O'Connor, L Strause, P Saltman, et al.
Circulation|April 1, 1990
Autonomic function in hypertension. Are there racial differences?R J Parmer, J H Cervenka, R A Stone, et al.
Regulatory Peptides|November 4, 2000
Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonismL Taupenot, S K Mahata, M Mahata, et al.
The Journal of Clinical Investigation|December 1, 1994
Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response elementD J Rozansky, H Wu, K Tang, et al.
Neuroscience|April 10, 1999
Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin a biosynthesisS K Mahata, M Mahata, H Wu, et al.
Journal of Hypertension|November 18, 2000
Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic riskM T Kailasam, R J Parmer, E A Tyrell, et al.
The Journal of Clinical Investigation|August 1, 1993
Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathwayR J Parmer, X P Xi, H J Wu, et al.
The Journal of Biological Chemistry|July 15, 1991
Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expressionH J Wu, D J Rozansky, R J Parmer, et al.
Pageof 8

Showing results (21-30 of 79) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|May 1, 1991
Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiencyD A Sica, R E Cutler, R J Parmer, et al.
Hypertension (Dallas, Tex. : 1979)|October 1, 1989
Molecular cloning of chromogranin A from rat pheochromocytoma cellsR J Parmer, A H Koop, M T Handa, et al.
Journal of Clinical Hypertension|December 1, 1987
Serum zinc is unaffected by effective captopril treatment of hypertensionD T O'Connor, L Strause, P Saltman, et al.
Circulation|April 1, 1990
Autonomic function in hypertension. Are there racial differences?R J Parmer, J H Cervenka, R A Stone, et al.
Regulatory Peptides|November 4, 2000
Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A(352-372)) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic antagonismL Taupenot, S K Mahata, M Mahata, et al.
The Journal of Clinical Investigation|December 1, 1994
Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response elementD J Rozansky, H Wu, K Tang, et al.
Neuroscience|April 10, 1999
Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin a biosynthesisS K Mahata, M Mahata, H Wu, et al.
Journal of Hypertension|November 18, 2000
Circulating amylin in human essential hypertension: heritability and early increase in individuals at genetic riskM T Kailasam, R J Parmer, E A Tyrell, et al.
The Journal of Clinical Investigation|August 1, 1993
Secretory protein traffic. Chromogranin A contains a dominant targeting signal for the regulated pathwayR J Parmer, X P Xi, H J Wu, et al.
The Journal of Biological Chemistry|July 15, 1991
Structure and function of the chromogranin A gene. Clues to evolution and tissue-specific expressionH J Wu, D J Rozansky, R J Parmer, et al.
Pageof 8